These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 19409226)

  • 1. Botulinum toxin type a (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction.
    Kitamura Y; Matsuka Y; Spigelman I; Ishihara Y; Yamamoto Y; Sonoyama W; Kamioka H; Yamashiro T; Kuboki T; Oguma K
    Neuroscience; 2009 Apr; 159(4):1422-9. PubMed ID: 19409226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two types of neurotransmitter release patterns in isolectin B4-positive and negative trigeminal ganglion neurons.
    Matsuka Y; Edmonds B; Mitrirattanakul S; Schweizer FE; Spigelman I
    Neuroscience; 2007 Jan; 144(2):665-74. PubMed ID: 17101230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy.
    Durham PL; Cady R; Cady R
    Headache; 2004 Jan; 44(1):35-42; discussion 42-3. PubMed ID: 14979881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms involved in modulation of trigeminal primary afferent activity in rats with peripheral mononeuropathy.
    Kitagawa J; Takeda M; Suzuki I; Kadoi J; Tsuboi Y; Honda K; Matsumoto S; Nakagawa H; Tanabe A; Iwata K
    Eur J Neurosci; 2006 Oct; 24(7):1976-86. PubMed ID: 17040479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [BK(Ca) channel agonist NS1619 and Kv channel antagonist 4-AP on the facial mechanical pain threshold in a rat model of chronic constriction injury of the infraorbital nerve].
    Liu CY; Li N; Zhao YF; Ma B
    Sheng Li Xue Bao; 2010 Oct; 62(5):441-9. PubMed ID: 20945047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial cell line-derived neurotrophic factor acutely modulates the excitability of rat small-diameter trigeminal ganglion neurons innervating facial skin.
    Takeda M; Kitagawa J; Nasu M; Takahashi M; Iwata K; Matsumoto S
    Brain Behav Immun; 2010 Jan; 24(1):72-82. PubMed ID: 19679180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripherally Administered Botulinum Toxin Type A Localizes Bilaterally in Trigeminal Ganglia of Animal Model.
    Waskitho A; Yamamoto Y; Raman S; Kano F; Yan H; Raju R; Afroz S; Morita T; Ikutame D; Okura K; Oshima M; Yamamoto A; Baba O; Matsuka Y
    Toxins (Basel); 2021 Oct; 13(10):. PubMed ID: 34678997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporomandibular joint inflammation potentiates the excitability of trigeminal root ganglion neurons innervating the facial skin in rats.
    Takeda M; Tanimoto T; Ikeda M; Nasu M; Kadoi J; Shima Y; Ohta H; Matsumoto S
    J Neurophysiol; 2005 May; 93(5):2723-38. PubMed ID: 15625101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intradermal injection of Botulinum toxin type A alleviates infraorbital nerve constriction-induced thermal hyperalgesia in an operant assay.
    Kumada A; Matsuka Y; Spigelman I; Maruhama K; Yamamoto Y; Neubert JK; Nolan TA; Watanabe K; Maekawa K; Kamioka H; Yamashiro T; Kuboki T; Oguma K
    J Oral Rehabil; 2012 Jan; 39(1):63-72. PubMed ID: 21793870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin.
    Gazerani P; Pedersen NS; Staahl C; Drewes AM; Arendt-Nielsen L
    Pain; 2009 Jan; 141(1-2):60-9. PubMed ID: 19004549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of purified botulinum type a neurotoxin to treat experimental trigeminal neuropathy in rats and patients with urinary incontinence and prostatic hyperplasia.
    Matsuka Y; Yokoyama T; Yamamoto Y; Suzuki T; Dwi Fatmawati NN; Nishikawa A; Ohyama T; Watanabe T; Kuboki T; Nagai A; Oguma K
    J Toxicol; 2012; 2012():648384. PubMed ID: 22745637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy.
    Filipović B; Matak I; Bach-Rojecky L; Lacković Z
    PLoS One; 2012; 7(1):e29803. PubMed ID: 22238656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of botulinum toxin A on mechanical and cold allodynia in a rat model of neuropathic pain.
    Park HJ; Lee Y; Lee J; Park C; Moon DE
    Can J Anaesth; 2006 May; 53(5):470-7. PubMed ID: 16636031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporomandibular joint inflammation decreases the voltage-gated K+ channel subtype 1.4-immunoreactivity of trigeminal ganglion neurons in rats.
    Takeda M; Tanimoto T; Nasu M; Matsumoto S
    Eur J Pain; 2008 Feb; 12(2):189-95. PubMed ID: 17584507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential.
    Meng J; Wang J; Lawrence G; Dolly JO
    J Cell Sci; 2007 Aug; 120(Pt 16):2864-74. PubMed ID: 17666428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-allodynic efficacy of botulinum neurotoxin A in a model of neuropathic pain.
    Luvisetto S; Marinelli S; Cobianchi S; Pavone F
    Neuroscience; 2007 Mar; 145(1):1-4. PubMed ID: 17218063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptic vesicle pools at diaphragm neuromuscular junctions vary with motoneuron soma, not axon terminal, inactivity.
    Mantilla CB; Rowley KL; Zhan WZ; Fahim MA; Sieck GC
    Neuroscience; 2007 Apr; 146(1):178-89. PubMed ID: 17346898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced excitability of nociceptive trigeminal ganglion neurons by satellite glial cytokine following peripheral inflammation.
    Takeda M; Tanimoto T; Kadoi J; Nasu M; Takahashi M; Kitagawa J; Matsumoto S
    Pain; 2007 May; 129(1-2):155-66. PubMed ID: 17127002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of TRPV1 expression in the trigeminal system by botulinum neurotoxin type-A.
    Shimizu T; Shibata M; Toriumi H; Iwashita T; Funakubo M; Sato H; Kuroi T; Ebine T; Koizumi K; Suzuki N
    Neurobiol Dis; 2012 Dec; 48(3):367-78. PubMed ID: 22820141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open study of botulinum-A toxin treatment of trigeminal neuralgia.
    Piovesan EJ; Teive HG; Kowacs PA; Della Coletta MV; Werneck LC; Silberstein SD
    Neurology; 2005 Oct; 65(8):1306-8. PubMed ID: 16247065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.